✦ LIBER ✦

Polyneuroendocrine therapy of advanced breast cancer with LHRH analogue, tamoxifen and the antiprolactinemic drug cabergoline: Phase 2 study

✍ Scribed by P. Lissoni; A. Ardizzoia; G. Cerea; M. Acquati; M. Simonelli; M. Vaghi; G. Tancini; G. Gardani

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

5. The combination of LHRH analogue and

✍ R.W. Blarney 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 149 KB

A randomised study to compare the effect

✍ W. Jonat; M. Kaufmann; R.W. Blamey; A. Howell; J.P. Collins; A. Coates; W. Eierm 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 587 KB

Intermittent/alternated therapy with tam

✍ L Beex; C Rose; H Mouridsen; J Jassem; M Nooy; J Estape; R Paridaens; M.J Piccar 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 172 KB

A phase 2 study of everolimus combined w

✍ Hurvitz, Sara A.; Dalenc, Florence; Campone, Mario; OâRegan, Ruth M.; Tjan-Hei 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 327 KB

Quality assurance of the 22961 EORTC tri

✍ Vassilis E. Kouloulias; Jean-Yves Giraud; Bernard J. Davis; Andrée Dusserre; Alf 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 233 KB

P40 The HOT study: Hormone replacement t

✍ M.C. Varricchio; B. Bonanni; A. Decensi 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 119 KB